FCGR1A and acute promyelocytic leukemia: More discrimination was identified with lower and more homogeneous MFI ratios of CD64 in non-APL/M5 patients (mean, 95% CI: 4.92, 4.42−5.42) compared to APL patients (Figure 6B, 205 APL, 556 non-APL/M5 patients).